Latest Turnaround News

The Warehouse Group (NZX:WHS) returned to profit in FY26 and cut net debt by more than 80%, despite broadly flat comparable sales. The recovery came with a clear catch: The Warehouse brand remains loss-making and shareholders will receive no final dividend.

Eminence Minerals has cut its FY2026 loss and raised its pro forma cash position to about A$5.4 million after selling the Mata da Corda titanium project. The portfolio is now centred on Hamersley iron ore and Brazilian rare earth exploration, but heritage litigation, ungranted tenure and future funding needs remain material constraints.

AdNeo Limited (ASX: AD1) nearly doubled operating revenue in FY26 and delivered its first full-year operating cash inflow, marking a sharp turnaround after the Learnt Global acquisition. The recovery remains incomplete, with a $3.97 million loss, significant current liabilities and an auditor-drawn material uncertainty over going concern.

RPM Automotive Group’s audited FY26 accounts confirm a sharp deterioration in earnings, a $4 million goodwill impairment and banking covenant non-compliance. Management is now treating FY27 as a transition year focused on cash generation and operational repair.

Kogan.com (ASX:KGN) crossed $1 billion in annual gross sales as stronger margins, cash generation and a Mighty Ape reset lifted FY26 results. The group returned to statutory profit, ended debt-free and declared another fully franked dividend.

Lanyon Investment Fund Active ETF (ASX:LNY) reported a sharp turnaround to a $30.3 million operating profit for the year ended 30 June 2026, driven overwhelmingly by gains on listed investments. Net assets rose to $146.2 million despite continued investor redemptions and a lower distribution than the prior year.

Intelligent Investor Equity Growth Fund returned to a $4.769 million operating profit in the year to 30 June 2026, after recording a $242,000 loss a year earlier. The improvement came with sharply higher distributions, but substantial redemptions reduced net assets and the fund faces an unresolved change of investment-manager ownership.

Nufarm is pairing a narrower crop-protection portfolio with heavier investment in seeds and tighter capital controls as it targets A$370 million to A$380 million in FY26 underlying EBITDA. The company has reaffirmed positive free cash flow, leverage of about 2.0 times and a A$50 million cost-saving program due to reach run-rate by the end of FY27.

Synlait’s operational recovery gathered pace in the second half, but the NZX-listed dairy processor still reported a NZ$75.4 million FY26 loss and negative operating cash flow. KPMG flagged a material uncertainty over going concern as the company prepares to refinance facilities due in 2027.

Group 6 Metals has reported a sharp FY2026 turnaround, backed by stronger tungsten sales, improved plant performance and A$55.7 million in operating cash flow. The result also carries substantial accounting benefits, while the next test is whether underground mining can make the improvement durable.

Global X S&P Biotech ETF (ASX:CURE) reported a AUD22.601 million profit for the year to 30 June 2026, reversing the prior year’s AUD2.863 million loss. The turnaround was driven overwhelmingly by gains in listed biotech securities and foreign exchange, rather than recurring income.

Bremworth has restored internal yarn production, cut costs and improved its inventory profile, but FY26 still ended with an NZ$11.4 million loss. The company now enters FY27 under new ownership and board dynamics, with positive operating cash flow still to be achieved.